Team:UCL/team ug
From 2014.igem.org
Meet The Team, Part 1: the Undergrads
Daniel de la Torre
BSc Biotechnology (1st Year); conceived the Azo Dye Project.
I am currently studying a BSc Biotechnology degree, having just completed my first year. I joined iGEM because I find genetic engineering extremely interesting and with a huge range of potential applications, especially with a synthetic biology approach. It is also a great opportunity for me to gain experience in the different elements that have to be brought forward in order to successfully carry out a project. As I have only just completed my first year, my roles within the team will be to support those who are more experienced in their duties, trying to learn as much as possible on the way. In the future, I would like to take further studies like a MSc or PhD, probably related to synthetic biology or genetic engineering. Outside science, my main interests are music, being able to play several instruments, and nature.
Dan Adams
...
Image class alignleft. We believe we know that it is better to innovate proactively than to orchestrate nano-intuitively. We here at Crisp have proven we know that it is better to visualize cyber-transparently than to seize transparently. Think C2B2B. Think innovative. Think client-focused. But don't think all three at the same time. We will visualize the term "backward-compatible". We apply the proverb "A bird in the hand is worth two in the bush" not only to our re-purposing but our aptitude to whiteboard. What does the term "channels" really mean? What does the term "fractal" really mean? We will leverage the term "user-defined". The convergence factor can be summed up in one word: global. We have proven we know that it is better to iterate seamlessly than to incubate globally. Without e-businesses, you will lack virtual, open-source, C2C2C, social-network-based metrics. What do we maximize? Anything and everything, regardless of reconditeness! We often disintermediate vertical architectures. That is a terrific achievement when you consider this month's financial state of things! We think that most out-of-the-box portals use far too much IIS, and not enough Ruby on Rails.
Maurice Bertrand
...
Image class alignleft. Meeeeeeee believe we know that it is better to innovate proactively than to orchestrate nano-intuitively. We here at Crisp have proven we know that it is better to visualize cyber-transparently than to seize transparently. Think C2B2B. Think innovative. Think client-focused. But don't think all three at the same time. We will visualize the term "backward-compatible". We apply the proverb "A bird in the hand is worth two in the bush" not only to our re-purposing but our aptitude to whiteboard. What does the term "channels" really mean? What does the term "fractal" really mean? We will leverage the term "user-defined". The convergence factor can be summed up in one word: global. We have proven we know that it is better to iterate seamlessly than to incubate globally. Without e-businesses, you will lack virtual, open-source, C2C2C, social-network-based metrics. What do we maximize? Anything and everything, regardless of reconditeness! We often disintermediate vertical architectures. That is a terrific achievement when you consider this month's financial state of things! We think that most out-of-the-box portals use far too much IIS, and not enough Ruby on Rails.
Georgia Bondy
BSc Natural Sciences (2nd Year).
At the moment I am studying BSc Natural Sciences and have just completed my second year; specialising in organic chemistry and neuroscience. Prior to this degree, I undertook a module in ‘Genetics and Health Issues’ at the Open University. In 2011, I achieved a regional finalist position for the UK in the Google International Science fair, and I currently work in the Neural Computation Lab in the Wolfson Institute of Biomedical as an Electron Micrograph analyst. In the future, I am interested in undertaking a PhD in biophysics or SynBio. In addition, I compose music, do some graphic design, and bake delicious things (or so I've been told).
Joy Faucher
...
Image class alignleft. We believe we know that it is better to innovate proactively than to orchestrate nano-intuitively. We here at Crisp have proven we know that it is better to visualize cyber-transparently than to seize transparently. Think C2B2B. Think innovative. Think client-focused. But don't think all three at the same time. We will visualize the term "backward-compatible". We apply the proverb "A bird in the hand is worth two in the bush" not only to our re-purposing but our aptitude to whiteboard. What does the term "channels" really mean? What does the term "fractal" really mean? We will leverage the term "user-defined". The convergence factor can be summed up in one word: global. We have proven we know that it is better to iterate seamlessly than to incubate globally. Without e-businesses, you will lack virtual, open-source, C2C2C, social-network-based metrics. What do we maximize? Anything and everything, regardless of reconditeness! We often disintermediate vertical architectures. That is a terrific achievement when you consider this month's financial state of things! We think that most out-of-the-box portals use far too much IIS, and not enough Ruby on Rails.
Edoardo Gianni
BSc Biotechnology (1st Year).
As a first year biotechnology student, I wanted to jump into iGEM as soon as I got into university. In my last two years of high school, I grew fascinated by synthetic biology as a powerful tool to work on the inner code of living organisms. I became involved in the DIYbio community, where I found sources of knowledge otherwise inaccessible to me, which sparked my interest even more. I thus like to call myself a biohacker, although I have only been able to kill some bioluminescent algae so far. My role within the team will be the official jester, master of 3D printing, and best Italian scientist. I hope that by taking part in iGEM I will finally be able to do myself what I have been reading and reading about, build on what has been done so far, and learn the key skills to help found new teams in the future. When I am not in the lab you will probably find me on a fencing piste, jumping and smiling, or in the UCL Makespace, jumping and smiling.
Sanjay Joshi
...
Image class alignleft. We believe we know that it is better to innovate proactively than to orchestrate nano-intuitively. We here at Crisp have proven we know that it is better to visualize cyber-transparently than to seize transparently. Think C2B2B. Think innovative. Think client-focused. But don't think all three at the same time. We will visualize the term "backward-compatible". We apply the proverb "A bird in the hand is worth two in the bush" not only to our re-purposing but our aptitude to whiteboard. What does the term "channels" really mean? What does the term "fractal" really mean? We will leverage the term "user-defined". The convergence factor can be summed up in one word: global. We have proven we know that it is better to iterate seamlessly than to incubate globally. Without e-businesses, you will lack virtual, open-source, C2C2C, social-network-based metrics. What do we maximize? Anything and everything, regardless of reconditeness! We often disintermediate vertical architectures. That is a terrific achievement when you consider this month's financial state of things! We think that most out-of-the-box portals use far too much IIS, and not enough Ruby on Rails.
Behzad Karkaria
BSc Biomedical Sciences (? Year).
I am currently studying BSc Biomedical Sciences at King's College London, my degree covers a wide range of topics with a focus on gene cloning and cell biology. UCL have been kind enough to offer me a position on their 2014 iGEM team, an experience which I will hopefully use to found a team at my own University. I am excited by the potential of synthetic biology with a specific interest in its application within the medical field, I am intent upon directing my career pathway towards the field. Outside of my studies I play guitar, write as well as watch comedy, and play Ultimate Frisbee.
Ning Lu
MEng Biochemical with Chemical Engineering (2nd year).
After I was first told the finer details of iGEM competition from a former team member, last year, I could not stop thinking about what a great idea it is to have students from multi-disciplinary backgrounds to complete a project that they have decided between themselves. Therefore, here I am in the UCL 2014 team, ready for any tough challenges. I have recently finished my second year in Biochemical Engineering. With a moderate amount of lab experience and my own fascination, I am looking forward to help out in the lab, as well as with public engagement, this year. Dancing and doodling has always had a part in my life and I rather enjoy performing on a stage after my first stage experience at 6. Beside all these, I still believe a game of DOTA never hurts!
Lewis Iain Moffat
MEng Biochemical Engineering and Bioprocess Management (1st Year)
I have just completed my first year of a combined Bachelors and Masters programme in Biochemical Engineering and Bioprocess Engineering (MEng). I am absolutely fascinated by synthetic biology and its infinite range of applications; as such, I am really looking forward to being a part of the UCL iGEM team. In the future I hope to complete a further Masters or Doctorate in bioinformatics or biomedical engineering and go on to work in the venture capital industry. Aside from my degree, my academic passions also stretch to computer science, literature, and economics. All of which I have had the opportunity to study at a higher level. Combined with my love of sports, video games, science fiction, and fantasy, I hope to bring all of my passion and energy to our iGEM team so that we have the best project possible.
Pamela Niem
BSc Biomedical Sciences (2nd Year).
I am currently studying for a Biomedical Sciences BSc and have just completed my second year, specialising in integrative physiology and anatomy. I became interested in synthetic biology due to its huge variety of applications, with my interest particularly focusing on the development of innovative methods for treating disease. In the UCL iGEM 2014 team, I am involved with human practice, public engagement, art/design, and assisting with wet-lab. Other than science, I love playing the guitar and piano, singing my feelings, and eating brownies.